Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how human bodies detect and respond to viruses and viral replication.

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to ...

Researchers had been studying the green alga Chlamydomonas reinhardtii for decades without seeing evidence of an active virus ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.